Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients

Summary

The investigators plan to see what factors can influence the durability of Exelon patch treatment in Korean patients with Alzheimer's disease.

Based on these results, the investigators will find the ways to maximize the effect and durability of Exelon patch on Korean patients with Alzheimer's disease.

After finishing this study, the investigators are going to present the study results at the international and national academic meetings or conferences.

Also the investigators expect that they can publish the result in a journal of in the field of neurology or dementia till the winter of 2010.

Conditions

• Alzheimer's Disease

Interventions

DRUG

Rivastigmine patch

Rivastigmine patch (5-10cm2, daily, 24hr)

Sponsors & Collaborators

• Seoul National University Bundang Hospital

  collaborator OTHER

• Seoul St. Mary's Hospital

  collaborator OTHER

• Korea University

  collaborator OTHER

• Bobath Memorial Hospital

  collaborator OTHER

• Chung-Ang University Hosptial, Chung-Ang University College of Medicine

  collaborator OTHER

• Hanyang University

  collaborator OTHER

• Kwandong University Myongji Hospital

  collaborator UNKNOWN

• Inha University Hospital

  collaborator OTHER

• SungAe General Hospital

  collaborator UNKNOWN

• Ewha Womans University

  collaborator OTHER

• Inje University

  collaborator OTHER

• Hanyang University Seoul Hospital

  collaborator OTHER

• Kyunghee University Medical Center

  collaborator OTHER

• Hallym University Medical Center

  collaborator OTHER

• Pusan National University Hospital

  collaborator OTHER

• Konyang University Hospital

  collaborator OTHER

• Wonkwang University Sanbon Medical Center

  collaborator UNKNOWN

• Yong-in Hyoja Geriatric Hospital

  collaborator UNKNOWN

• Jeju National University

  collaborator OTHER

• Dong-A University Hospital

  collaborator OTHER

• Seoul National University Hospital

  lead OTHER

Principal Investigators

• SangYun Kim, MD, PhD · Seoul National University College of Medicine & Seoul National University Bundang Hospital

• Dong Won Yang, MD, PhD · The Catholic University of Korea

• Moon Ho Park, MD, PhD · Korea University College of Medicine & Korea University Ansan Hospital

• Hae Ri Na, MD · Bobath Memorial Hospital

• Young-Chul Yoon, MD, PhD · Chungang University College of Medicine & Chungang University Hospital

• Seong-Ho Koh, MD, PhD · Hanyang University College of Medicine & Hanyang University Guri Hospital

• Hyun Jeong Han, MD, PhD · Kwandong University College of Medicine & Myongji Hospital

• Bon D. Ku, MD, PhD · Kwandong University College of Medicine & Myongji Hospital

• Seong-Hye Choi, MD, PhD · Inha University College of Medicine & Inha University Hospital

• Jung Seok Lee, MD · Jeju National University College of Medicine & Jeju National University Hospital

• Jun-Seong Lim, MD · SungAe General Hospital

• Jung Eun Kim, MD · Ewha Womans University School of Medicine & Ewha Womans University Mokdong Hospital

• Jeong Yeon Kim, MD · Inje University College of Medicine & Sanggye Paik Hospital

• Hee-Jin Kim, MD · Hanyang University College of Medicine & Hanyang University Seoul Hospital

• Seung Hyun Kim, MD, PhD · Hanyang University College of Medicine & Hanyang University Seoul Hospital

• Key Hung Park, MD, PhD · Kyung Hee University College of Medicine & Kyung Hee University Medical Center

• Kyung Won Park, MD, PhD · Dong-A University College of Medicine & Dong-A University Medical Center

• Hui Chul Choi, MD, PhD · Hallym University College of Medicine & Hallym University Chunchon Hospital

• Eun-Joo Kim, MD · Pusan National University School of Medicine & Pusan National University Hospital

• Bora Yoon, MD · Konyang University School of Medicine & Konyang University Hospital

• Hyun Duk Yang, MD · Wonkwang University College of Medicine & Wonkwang University Sanbon Medical Center

• Youngsoon Yang, MD · Yong-in Hyoja Geriatric Hospital

• Hee-Jung Seo, MD · Yong-in Hyoja Geriatric Hospital

Eligibility

Min Age

51 Years

Max Age

85 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2009-06-30

Primary Completion

2011-06-30

Completion

2011-07-31

Countries

• South Korea

Study Locations